HTG Molecular Diagnostics Inc. (HTGM)

4.37
NASDAQ : Health Technology
Prev Close 4.59
Day Low/High 4.31 / 4.56
52 Wk Low/High 1.65 / 5.83
Avg Volume 523.40K
Exchange NASDAQ
Shares Outstanding 28.36M
Market Cap 130.15M
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Six Biotechnology Names on My Watch List

Six Biotechnology Names on My Watch List

After recent weakness in the biotech sector, here are some names to start watching.

Indexes Hold Onto Week's Gains

Indexes Hold Onto Week's Gains

Stocks might have been expected to sell off ahead of a three-day weekend and amid trade tensions between the U.S. and its largest trading partners, but they didn't.

3 Stock Trades I'm Looking to Make on the U.S.-Mexico Trade Deal

3 Stock Trades I'm Looking to Make on the U.S.-Mexico Trade Deal

There are several key points to keep in mind as you digest this news.

Strength in Growth Names Is Giving the Market a More Upbeat Feel

Strength in Growth Names Is Giving the Market a More Upbeat Feel

Apple in particular is helping the bullish cause.

Two Small Caps On the Cusp of Being Discovered

Two Small Caps On the Cusp of Being Discovered

HTG Molecular Diagnostics and Amyris are poised for substantial growth.

This Market Lacks Strong Leadership

This Market Lacks Strong Leadership

The biggest negative I see in the market right now is how poorly certain groups are acting.

Interesting HTGM Put And Call Options For December 21st

Investors in HTG Molecular Diagnostics Inc saw new options become available this week, for the December 21st expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Biotechs Take the Lead This Morning

Biotechs Take the Lead This Morning

Whether this market continues to bounce is going to depend a great degree on the FAANG names.

Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections

Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections

Watch for these upstart names to topple some big-caps going forward.

Expect Another Attack on Support Levels

Expect Another Attack on Support Levels

While support held on a tough day, those levels look precarious.

Dip Buyers Are Losing Their Confidence -- And They Have No Interest in Facebook

Dip Buyers Are Losing Their Confidence -- And They Have No Interest in Facebook

The longer the stock market goes without a better bounce, the bigger the risk.

My Cash Levels Are Growing -- But Not My Appetite for Buying Stocks

My Cash Levels Are Growing -- But Not My Appetite for Buying Stocks

We are in a middle ground right now without enough strong movement in either direction.

Twitter Is One of 4 Stocks I'm Focused on as Dip Buying Works Yet Again

Twitter Is One of 4 Stocks I'm Focused on as Dip Buying Works Yet Again

Look for this bounce to slow down quickly and some weakness this afternoon.

Buying Opportunities Present Themselves; Wells Fargo Directors to Leave -- ICYMI

Buying Opportunities Present Themselves; Wells Fargo Directors to Leave -- ICYMI

Here's what you need to know for Friday, March 2.

Using Market Softness to Add to Stocks Incrementally

Using Market Softness to Add to Stocks Incrementally

I think we'll probably see some shifting in the tariff policy over the weekend, giving the market some relief.

I'm Not Feeling There's Support for a Bounce Now

I'm Not Feeling There's Support for a Bounce Now

I'm focused on managing positions and am doing very little new buying at this point.

Being Patient Until I Can Trust This Market More

Being Patient Until I Can Trust This Market More

It is very easy to force trades in this sort of environment.

Choppy Market Action This Morning

Choppy Market Action This Morning

The good news is that there is some stock picking that is working well.

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Here's what you need to know now for Wednesday, Feb. 14.

Biotech Heats Up as Fear of Missing Out Returns

Biotech Heats Up as Fear of Missing Out Returns

It's hard to believe the bounce will continue to run in V-shaped fashion.

Seeing Good Action in Several Stocks, Buying More MJ, Gold

Seeing Good Action in Several Stocks, Buying More MJ, Gold

It is a very different market environment now which can be very rewarding depending on your style.

Focused on Two Sectors

Focused on Two Sectors

If we have a little consolidating action here the buyers will start pushing again.

The Character of the Market Has Shifted

The Character of the Market Has Shifted

The big question right now is to what degree should you be looking to take positions in individual stocks you may like.

TheStreet Quant Rating: D+ (Sell)